Chlorzoxazone Tablet
NDC Package 0254-2005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Chlorzoxazone tablets is chlorzoxazone is used to treat muscle spasms/pain. This formulation utilizes a tablet delivery system. Marketed by Endo Usa, Inc., this product is identified by NDC 0254-2005 and is authorized under FDA application ANDA212743.

Identification & Billing

NDC Package Code
0254-2005-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
00254200501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Chlorzoxazone
Non-Proprietary Name
Chlorzoxazone
Substance Name
Chlorzoxazone
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Chlorzoxazone is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Regulatory & Marketing

Labeler Name
Endo Usa, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA212743
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-04-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0254-2005-01 identifies a specific commercial package of 100 tablet in 1 bottle of Chlorzoxazone, a human prescription drug labeled by Endo Usa, Inc.. This tablet is formulated for oral use and contains chlorzoxazone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Endo Usa, Inc. on November 04, 2020. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Chlorzoxazone is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

How is this Endo Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00254200501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0254-2005-01
11-Digit CMS (5-4-2)
00254-2005-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.